Factors Predicting Adherence to Dual Antiplatelet Medications among Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention

Main Article Content

Chakariya Boonkua
Doungrut Wattanakitkrileart
Sarinrut Sriprasong
Chatkanok Dumavibhat

Abstract

Purpose: This study aimed to examine the predictive power of perceived severity of disease, barriers to receive treatment, complexity of medication regimen and medication knowledge on the adherence to dual antiplatelet medications among patients with acute coronary syndrome at post percutaneous coronary intervention.


Design: Correlational predictive research design.


Methods: The sample consisted of 134 patients with acute coronary syndrome after percutaneous coronary intervention at least one month, and having a treatment plan of using dual antiplatelet for at least one year. Data were collected at the heart and medicine clinics of a tertiary hospital in Bangkok using demographic characteristics questionnaire, Hill-Bone Medication Adherence Korean scale, Perceived Severity of Disease Questionnaire, Barriers to Receive Treatment Questionnaire, The Medication Regimen Complexity Index, and Dual Antiplatelet Knowledge Questionnaire. Descriptive statistics and logistic regression analysis were used for the analysis.


Main findings: The finding revealed that 77.6% of the participants were male with mean age of 60.9 years (SD = 12.8). Taking aspirin with brilinta/ticagrelor 56.7%, aspirin with apolets/plavix/clopidogrel 43.3%. Seventy-four point six percent of the sample had high level of dual antiplatelet medications adherence. Perceived severity of disease, barriers to receive treatment, complexity of medication regimen and medication knowledge could together predict the adherence to dual antiplatelet medications among patients with ACS after the intervention by 13.1%. Finally, high level of perceived severity of disease and good level of medication knowledge could significantly predict the adherence to dual antiplatelet medications (OR = .37, 95%CI [.15, .92], p = .034; OR = 3.82, 95%CI [1.07, 13.58], p = .038, respectively).


Conclusion and recommendations: High level of perceived severity of disease and good level of medication knowledge affects the adherence to dual antiplatelet medications. Nurses should give advice about the severity of ACS and knowledge on dual antiplatelet medications to improve the adherence.

Downloads

Download data is not yet available.

Article Details

How to Cite
Boonkua ช., Wattanakitkrileart ด. . ., Sriprasong ศ. ., & Dumavibhat ฉ. . (2022). Factors Predicting Adherence to Dual Antiplatelet Medications among Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention. Nursing Science Journal of Thailand, 40(3), 60–75. Retrieved from https://he02.tci-thaijo.org/index.php/ns/article/view/251360
Section
Research Papers

References

Basit H, Malik A, Huecker MR. Non ST segment elevation myocardial infarction [Internet]. Treasure Island, FL: StatPearls Publishing; [updated 2019 Jan; cited 2020 Aug 15]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513228/?%20report=reader.

Ministry of Public Health. Thai ACS registry 2019 [Internet]. Nonthaburi: Ministry of Public Health; 2019 [cited 2020 Aug 20]. Available from: http://122.155.134.12/document/ACS_2019.pdf. (in Thai).

Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fieisher LA, et al. 2016 ACC/AHA Guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease : a report of the American College of Cardiology/American heart association task force on clinical practice guidelines: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention, 2011 ACCF/AHA guideline for coronary artery bypass graft surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016;134(10):e123-55. doi: 10.1161/CIR.0000000000000404.

Luu NM, Dinh AT, Nguyen TTH, Nguyen VH. Adherence to antiplatelet therapy after coronary intervention among patients with myocardial infarction attending Vietnam national heart institute. BioMed Res Int. 2019;2019:6585040. doi: 10.1155/2019/6585040.

Valgimigli M, Bueno H, Byrne RA, Collet J-P, Costa F, Jeppsson A, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39(3):213-60. doi: 10.1093/eurheartj/ehx419.

World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003. 196 p.

DiMatteo MR, Haskard KB, Williams SL. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care. 2007;45(6):521-8. doi: 10.1097/MLR.0b013e318032937e.

Surasrisakul I, Ua-Kit N. Predicting factors of medication adherence among myocardial infarction patients after underwent percutaneous coronary intervention. Journal of The Police Nurses. 2012;4(2):60-70. (in Thai).

Alrabiah Z, Wajid S, Alsulaihim I, Alghadeer S, Alhossan A, Babelghaith SD, et al. Adherence to prophylactic dual antiplatelet therapy in patients with acute coronary syndrome-A study conducted at a Saudi university hospital. Saudi Pharm J. 2020;28(3):369-73. doi: 10.1016/j.jsps.2020.01.018.

Shemisa K, hatt A, Cheeran D, Clark C, Alvarez K, Vigen R, et al. Premature discontinuation of ticagrelor among patients who underwent PCI for ACS in a large urban safety net hospital. E-Cronicon Cardiology. 2018;5(5):266-72.

Castellano JM, Sanz G, Penalvo JL, Bansilal S, Fernandez-Ortiz A, Alvarez L, et al. A polypill strategy to improve adherence. J Am Coll Cardiol. 2014;64(20):2071-82. doi: 10.1016/j.jacc.2014.08.021.

Penpimol P, Charoenkitkarn V, Wattanakitkrileart D, Dumavibhat C. The influence of perceived medication necessity, medication concern, patient-healthcare provider communication, and complexity of medical regimens on medication adherence in patients with acute coronary syndrome after hospitalization. Journal of The Royal Thai Army Nurses. 2016;17(3):149-57. (in Thai).

Czarny MJ, Nathan AS, Yeh RW, Mauri L. Adherence to dual antiplatelet therapy after coronary stenting: a systematic review. Clin Cardiol. 2014;37(8):505-13. doi: 10.1002/clc.22289.

Custodis F, Rohlehr F, Wachter A, Bohm M, Schulz M, Laufs U. Medication knowledge of patients hospitalized for heart failure at admission and after discharge. Patient Prefer Adherence. 2016;10:2333-9. doi: 10.2147/PPA.S113912.

Sriphet K, Seneha C, Sriprasong S, Kanokslip A. Factors influencing antiplatelet adherence among patients with acute ST- elevation myocardial infarction in post percutaneous coronary intervention. Thai Journal of Cardio-Thoracic Nursing. 2019;30(2):111-25. (in Thai).

Vele L. Analysis of binary dependent variables using linear probability model and logistic regression: a replication study [master’s thesis]. Uppsala, Sweden: Uppsala University; 2019 [cited 2020 Aug 29]. Available from: https://www.diva-portal.org/smash/get/diva2:1324943/FULLTEXT01.pdf.

Trongsakul S, Lambert R, Clark A, Wongpakaran N, Cross J. Development of the Thai version of mini-cog, a brief cognitive screening test. Geriatr Gerontol Int. 2015;15(5):594-600. doi: 10.1111/ggi.12318.

Song Y, Han H-R, Song H-J, Nam S, Nguyen T, Kim MT. Psychometric evaluation of hill-bone medication adherence subscale. Asian Nurs Res. 2011;5(3):183-8. doi: 10.1016/j.anr.2011.09.007.

Tanukaew D, Wattanakitkrileart D, Sriyuktasuth A, Chattranukulchai P. Factors predicting medication adherence in patients with essential hypertension [master’s thesis]. Bangkok: Mahidol University; 2021. 178 p. (in Thai).

Nau DP, Ellis JJ, Kline-Rogers EM, Mallya U, Eagle KA, Erickson S. Gender and perceived severity of cardiac disease: evidence that women are “tougher”. Am J Med. 2005;118(11):1256-61. doi: 10.1016/j.amjmed.2005.08.006.

Wattanakitkrileart D, Khongton W, Sumonviwat T, Dejsomritrutai W. The influence of inhaler technique, exacerbation, age, and barrier to receiving care on adherence to inhaled medications in patients with COPD. Nursing Science Journal of Thailand. 2020;38(2):74-87. (in Thai).

George J, Phun Y-T, Bailey MJ, Kong DCM, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369-76. doi: 10.1345/aph.1D479.

Roth GA, Morden NE, Zhou W, Malenka DJ, Skinner J. Clopidogrel use and early outcomes among older patients receiving a drug-eluting coronary artery stent. Circ Cardiovasc Qual Outcomes. 2012;5(1):103-12. doi: 10.1161/CIRCOUTCOMES.111.962704.

Becker MH. The health belief model and sick role behavior. Health Educ Monogr. 1974;2(4):324-508. doi: 10.1177/109019817400200407.

Polsook R, Aungsuroch Y, Thanasilp S. Medication adherence among persons with post-acute myocardial infarction. Songklanakarin Journal of Science Technology. 2016;38(6):611-20.

Most read articles by the same author(s)